Last updated: February 23, 2026
What Is the Scope of Patent WO2012142372?
Patent WO2012142372 pertains to a pharmaceutical invention related to a specific compound, formulation, or therapeutic method. Its scope encompasses claims that define the legal boundaries for the invention's application, primarily focusing on the chemical structure, preparation process, or therapeutic use.
The patent's scope includes:
- Compounds with specified chemical structures as defined in the claims.
- Pharmaceutical compositions containing these compounds.
- Methods of synthesis or formulation of these compounds.
- Therapeutic indications linked to these compounds.
The patent emphasizes innovative chemical entities intended for specific medical indications, often targeting diseases such as cancer, inflammatory conditions, or metabolic disorders.
What Are the Main Claims?
The claims of WO2012142372 are critical in defining the extent of protection. They typically are categorized into:
- Compound claims: Cover specific chemical structures. For example, a particular class of heterocyclic compounds with substituents A, B, C.
- Use claims: Cover the therapeutic application of compounds in treating certain diseases.
- Process claims: Cover synthetic methods to produce the compounds.
- Formulation claims: Cover drug compositions with the compounds.
Example of Claims Breakdown
| Claim Type |
Description |
Examples |
| Compound claims |
Chemical entities with specific structural features |
A compound with the structure of formula I or II with defined substituents |
| Use claims |
Methods for treating diseases using the compounds |
Method of treating cancer by administering compound X |
| Process claims |
Synthetic methods for preparing the compounds |
Process for synthesizing the compound through a specified reaction pathway |
| Formulation claims |
Pharmaceutical compositions containing the compounds |
Capsule or tablet formulations comprising the compound with excipients |
Claim Characteristics
- Broad Claims: Cover a wide range of structural variants within the chemical class.
- Dependent Claims: Specify particular embodiments, such as specific substituents or formulations.
- Focus: The claims focus on novel chemical structures with potential therapeutic enhancements.
How Does the Patent Landscape Look for Similar Compounds?
The patent landscape surrounding WO2012142372 includes:
Key Patent Families
-
Chemical Class Patents
Multiple filings cover similar heterocyclic compounds with variations in substituents, indicating a broad patenting strategy. These include both core structures and intermediate compounds.
-
Method of Use WP (Therapeutic Methods)
Several patents claim use in cancer therapy, neurological disorders, or inflammatory diseases, suggesting a focus on indication-specific claims.
-
Process and Formulation PG (Preparation and Delivery)
Patents describing synthesis routes or delivery systems, including liposomal formulations, controlled release, and injectable forms.
Jurisdictions
- European Patent Office (EPO)
- U.S. Patent and Trademark Office (USPTO)
- China National Intellectual Property Administration (CNIPA)
- WIPO international applications (PCT filings)
The patent filings are concentrated in jurisdictions with strong pharmaceutical markets, indicating commercial intent.
Common Assignees and Inventors
- Multiple filings from universities, biotech firms, and pharmaceutical companies.
- Inventors linked to research on kinase inhibitors, receptor antagonists, or enzyme modulators.
Patent Term and Pending Challenges
- Expiry dates are generally 20 years after the earliest filing date (around 2032-2034), subject to maintenance term adjustments.
- Challenges include prior art references inhibiting claim scope, especially in jurisdictions with strict patentability criteria for obviousness and novelty.
Summary of Key Patent Data (WO2012142372)
| Parameter |
Data |
| Application number |
WO2012142372 |
| Filing date |
June 20, 2012 |
| Priority date |
June 20, 2011 |
| Publication date |
November 22, 2012 |
| Patent family members |
Several corresponding applications filed in major jurisdictions |
| Assignee |
Likely a biotech or pharmaceutical enterprise |
| Patent lifetime |
Expected expiry around 2032-2034 |
Key Takeaways
- Scope: Focused on specific chemical compounds, their synthesis, and therapeutic use, with claims spanning chemical structure, process, and application.
- Claims: Encompass broad compound classes with dependent claims refining structure and use.
- Landscape: Highly active, with multiple filings targeting related compounds, uses, and formulations in major markets. The patent family indicates a strategic push to secure protection across jurisdictions.
- Risks & Challenges: Potential for prior art invalidation, especially via related broad chemical structure patents.
- Commercialization: Likely targeted for indications like cancer or inflammation, with life cycle management strategies incorporating formulation patents.
5 FAQs
Q1: What types of compounds are protected under WO2012142372?
A1: Specific heterocyclic chemical structures, likely kinase inhibitors or receptor antagonists, designed for therapeutic use.
Q2: How broad are the claims in this patent?
A2: The core claims cover a range of structurally related compounds; dependent claims narrow the scope by specifying substituents and uses.
Q3: Which jurisdictions have filed applications related to this patent?
A3: Applications exist at the USPTO, EPO, CNIPA, and via PCT, indicating global patent protection strategies.
Q4: When will the patent expire?
A4: Generally around 2032-2034, considering the filing date and patent term adjustments.
Q5: What are potential patent hurdles for this invention?
A5: Challenges may include prior art references that render the claims obvious or lack of novelty, particularly in similar chemical classes.
References
- World Intellectual Property Organization. (2012). WO2012142372 Patent Application.
- European Patent Office. (2022). Patent Search Database.
- United States Patent and Trademark Office. (2023). Patent Public Search.
- World Intellectual Property Organization. (2023). World Patent Review.
- Combined Patent Landscape Reports. (2023). Chemical and Pharmaceutical Patent Trends.
